Septum-guided Segmentectomy for Deep Early-stage Lung Cancer (SGS2512)
Recruiting
N/A
Interventional Study
Non-small Cell Lung Cancer
Early-stage Lung Cancer
Deep-seated Lung Nodules
Solid-dominant Lung Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 89 (estimated)
- Sponsor
- Shanghai Chest Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the safety and effectiveness of a specialized surgical technique called "Septum-guided Segmentectomy" for treating early-stage lung cancer located deep within the lung tissue.Standard surgery for lung cancer often involves removing an entire lung lobe (lobectomy), which can significantly reduce a patient's breathing capacity. For small tumors, removing only…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-80 years
* Clinical stage IA (cT1a-bN0M0)
* tumor diameter ≤ 2 cm
* Pathological feature: Solid-dominant lesion (CTR \> 0.5)
* Tumor location: Deep-seated within the lung parenchyma (inner 2/3), defined as the tumor center being located in the inner 2/3 region of the lu…
Contacts